Zrosk Investment Management Limited

Zrosk Investment Management Limited is an African-focused private equity firm dedicated to catalyzing growth in underserved and underrepresented markets. The firm emphasizes alignment of interests among investors, employees, and founders, aiming to hold significant stakes in the businesses it supports. Zrosk typically invests between $100,000 and $4,000,000, focusing on stages from pre-seed to Series B, and has a preference for second-time founders or those with senior-level experience in their industry. The firm's investment horizon varies by product, with early-stage equity investments having a horizon of 7-10 years. Zrosk's strategic investments take a permanent capital approach to investing in high-growth small and middle-market businesses operating in the real sector of the African economy. The firm is sector agnostic but currently has an interest in agriculture, mining, manufacturing, renewables, fitness, and the creative industry. Zrosk takes a hands-on approach, usually holding significant stakes (25-50%) in the businesses it supports, and aims to become permanent owners. The firm focuses on operational enhancement, developing growth strategies, sourcing key personnel, and implementing best corporate practices. In October 2024, Zrosk acquired a 10% equity stake in MeCure Industries Plc, one of Nigeria's leading pharmaceutical companies. This investment reflects the firm's confidence in MeCure's long-term growth strategy and its commitment to delivering quality healthcare solutions to millions of Nigerians. With Zrosk's support, MeCure is well-positioned to execute its ambitious expansion plans and continue making a positive impact on the healthcare sector in Nigeria and beyond.

Preference for second-time founders or those with senior-level experience in their industry, Focus on early-stage companies addressing global challenges, Alignment of interests among investors, employees, and founders